Endoscopic Full-Thickness Resection of Submucosal Gastric Tumors

Renteln, Daniel von; Rösch, Thomas; Kratt, Thomas; Denzer, Ulrike W.; El‐Masry, Muhammad Abbas; Schachschal, Guido

doi:10.1007/s10620-012-2039-1

Cited by 43 publications

(29 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thereafter, one of the tumors was removed endoscopically using a novel prototype for endoscopic fullthickness-resection (FTRD, full-thickness-resection device; Ovesco Endoscopy AG, Tuebingen, Germany) [12].…”

Section: Diagnostic and Therapeutic Routesmentioning

confidence: 99%

Therapeutic Management of Submucosal Gastric Tumors: A Series of Six Cases with Ectopic Pancreas in the Stomach and Description of a Novel Endoscopic Full-Thickness Resection Technique of the Gastric Wall

Archid¹,

Kratt²,

Schneider³

2016

J Gastrointest Dig Syst

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Diagnostic and Therapeutic Routesmentioning

confidence: 99%

Therapeutic Management of Submucosal Gastric Tumors: A Series of Six Cases with Ectopic Pancreas in the Stomach and Description of a Novel Endoscopic Full-Thickness Resection Technique of the Gastric Wall

Archid¹,

Kratt²,

Schneider³

2016

J Gastrointest Dig Syst

Self Cite

View full text Add to dashboard Cite

show abstract

“…En-bloc resection is widely performed for the treatment of definite GISTs. Currently, minimally invasive local resection techniques, such as hybrid natural orifice transluminal endoscopic surgery (NOTES), which consists of endoscopic full-thickness resection (EFTR), have been developed for the treatment of endoluminal GISTs (2,3). Furthermore, endoscopic diagnostic methods for SETs have been proposed (4,5), including our safe and reliable method of bloc biopsy performed under a direct endoscopic view by using submucosal endoscopy with a mucosal flap method (SEMF) (4).…”

Section: Introductionmentioning

confidence: 99%

Indications of endoscopic submucosal dissection for symptomatic benign gastrointestinal subepithelial or carcinoid tumors originating in the submucosa

Kobara

Mori

Rafiq

et al. 2013

Molecular and Clinical Oncology

View full text Add to dashboard Cite

Abstract. Endoscopic submucosal dissection (ESD) for upper gastrointestinal (GI) subepithelial tumors (SETs) originating in the muscularis propria (MP) layer is associated with numerous issues regarding secure closure and measures against accidental perforation. However, symptomatic benign GI SETs or carcinoid tumors originating in the submucosa (SM) may be safely resected en-bloc using ESD. In this study, the feasibility and safety of ESD as a novel method for endoscopic resection for such GI SETs revealed on endoscopic ultrasonography (EUS) was investigated. A total of 12 consecutive cases of patients with symptomatic benign SETs (n=3; 1 esophageal hemangioma and 2 gastric lipomas) or small carcinoid tumors (n=9; <10 mm, with an extremely low risk of metastasis) originating in the SM as determined on EUS, between March, 2009 and April, 2013, were retrospectively reviewed. The lesions were resected by ESD after confirming that the tumors originated from the SM. The complication rate following en-bloc resection was also determined. En-bloc resection was achieved in all 12 cases, the mean procedure time was 45 min (range, 20-120 min) and no complications occurred intra-or postoperatively. There was no tumor recurrence or disease-related mortality reported during the follow-up period (median follow-up time, 13.4 months). Histopathological curative resection was achieved with ESD without complications in all 9 cases with carcinoid tumors. Therefore, if EUS reveals a SET originating in the SM without infiltration of the MP and resection is indicated due to the presence of abdominal symptoms, ESD may be a feasible option for diagnostic treatment with minimal invasiveness. However, larger-scale prospective studies are required to establish the feasibility and safety of this procedure.

show abstract

“…The latest National Comprehensive Cancer Network (NCCN) task force report has suggested that all GISTs 2 cm or larger should be resected [3]. With the progressive increase in experience in endoscopic submucosal dissection (ESD), endoscopic full-thickness resection (EFTR) without laparoscopic assistance has been applied to remove GISTs with extra-luminal growth and/or close proximity to the serosa [4][5][6][7][8][9]. The key step of the EFTR procedure is the complete closure of wall defects left by full-thickness resection and thereby avoiding surgical intervention.…”

mentioning

confidence: 99%

Application of novel endoloops to close the defects resulted from endoscopic full-thickness resection with single-channel gastroscope: a multicenter study

Shi

Chen

et al. 2016

Surg Endosc

View full text Add to dashboard Cite

show abstract

Endoscopic Full-Thickness Resection of Submucosal Gastric Tumors

Cited by 43 publications

References 34 publications

Therapeutic Management of Submucosal Gastric Tumors: A Series of Six Cases with Ectopic Pancreas in the Stomach and Description of a Novel Endoscopic Full-Thickness Resection Technique of the Gastric Wall

Therapeutic Management of Submucosal Gastric Tumors: A Series of Six Cases with Ectopic Pancreas in the Stomach and Description of a Novel Endoscopic Full-Thickness Resection Technique of the Gastric Wall

Indications of endoscopic submucosal dissection for symptomatic benign gastrointestinal subepithelial or carcinoid tumors originating in the submucosa

Application of novel endoloops to close the defects resulted from endoscopic full-thickness resection with single-channel gastroscope: a multicenter study

Contact Info

Product

Resources

About